Skip to main content
. 2018 Aug 8;25:62. doi: 10.1186/s12929-018-0464-y

Fig. 6.

Fig. 6

Impact on GBM cell invasion on targeting IL-8/CXCR1/2 (a) Spheroid invasion assay in U-87MG and LN-18 cell line (b) Graph showing relative invasion of U-87 MG and LN-18 cell lines. The statistically significant decrease in spheroid invasion was observed on day 3 in U-87MG cells treated with Reparixin-l-lysine (p < 0.05). In LN-18 statistically significant difference in spheroid invasion was evident from day 1with p < 0.05, which became even more prominent on day 3 with p < 0.01